During the past decade, Anne Arundel Urology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anne Arundel Urology" #1 collaborator was "Allergan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Anne Arundel Urology" are "Bladder Cancer" (2 trials), "Cystitis, Interstitial" (2 trials), "Dietary Hyperoxaluria" (1 trials), "Fractures" (1 trials) and "Hyperoxaluria" (1 trials). Many other conditions were trialed in "Anne Arundel Urology" in a lesser frequency.

Most popular intervention types in "Anne Arundel Urology" are "Drug" (6 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apaziquone" (2 trials), "LiRIS Placebo" (2 trials), "LiRIS®" (2 trials) and "ALLN-177 high dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anne Arundel Urology" are 3 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Anne Arundel Urology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Anne Arundel Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Anne Arundel Urology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".